Lee Ainslie - Maverick Capital
Holding/activity history for Gilead Sciences (GILD)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2021 Q1 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2020 Q4 | 10,370 | 0.01 | Reduce 77.15% | 0.03 | $58.24 |
| 2020 Q3 | 45,380 | 0.05 | Buy | 0.05 | $63.20 |
| 2020 Q1 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2019 Q4 | 25,365 | 0.02 | Add 56.96% | 0.01 | $64.97 |
| 2019 Q3 | 16,160 | 0.02 | Buy | 0.02 | $63.37 |
| 2017 Q3 | 0 | 0 | Sell 100.00% | 0.02 | |
| 2017 Q2 | 24,760 | 0.02 | Add 161.73% | 0.01 | $70.80 |
| 2017 Q1 | 9,460 | 0.01 | Add 11.03% | 0.00 | $67.97 |
| 2016 Q4 | 8,520 | 0.01 | Add 8.12% | 0.00 | $71.60 |
| 2016 Q3 | 7,880 | 0.01 | Add 12.25% | 0.00 | $79.06 |
| 2016 Q2 | 7,020 | 0.01 | Add 24.69% | 0.00 | $83.48 |
| 2016 Q1 | 5,630 | 0.01 | Add 140.60% | 0.01 | $91.83 |
| 2015 Q4 | 2,340 | 0.00 | $101.28 | ||
| 2015 Q3 | 2,340 | 0.00 | $98.29 | ||
| 2015 Q2 | 2,340 | 0.00 | Reduce 11.70% | 0.00 | $117.09 |
| 2015 Q1 | 2,650 | 0.00 | Buy | 0.00 | $98.11 |